company background image
A044

Eagle Veterinary TechnologyLtdKOSDAQ:A044960 Stock Report

Market Cap

₩104.0b

7D

-0.7%

1Y

-11.0%

Updated

25 Nov, 2021

Data

Company Financials
A044960 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

A044960 Stock Overview

Eagle Veterinary Technology Co.,Ltd manufactures and sells animal health care products in South Korea.

Price History & Performance

Summary of all time highs, changes and price drops for Eagle Veterinary TechnologyLtd
Historical stock prices
Current Share Price₩8,230.00
52 Week High₩13,200.00
52 Week Low₩6,900.00
Beta0.83
1 Month Change-1.32%
3 Month Change-5.18%
1 Year Change-11.03%
3 Year Change104.22%
5 Year Change36.48%
Change since IPO-79.14%

Recent News & Updates

Apr 11
Do Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) Earnings Warrant Your Attention?

Do Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) Earnings Warrant Your Attention?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...

Mar 21
Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Seems To Use Debt Rather Sparingly

Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Seems To Use Debt Rather Sparingly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Feb 21
Is Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Recent Price Movement Underpinned By Its Weak Fundamentals?

Is Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Recent Price Movement Underpinned By Its Weak Fundamentals?

It is hard to get excited after looking at Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) recent performance, when...

Jan 10
Investors Who Bought Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Shares Three Years Ago Are Now Up 84%

Investors Who Bought Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Shares Three Years Ago Are Now Up 84%

It might be of some concern to shareholders to see the Eagle Veterinary Technology Co.,Ltd ( KOSDAQ:044960 ) share...

Shareholder Returns

A044960KR PharmaceuticalsKR Market
7D-0.7%-2.4%-0.1%
1Y-11.0%-31.0%11.5%

Return vs Industry: A044960 exceeded the KR Pharmaceuticals industry which returned -28.9% over the past year.

Return vs Market: A044960 underperformed the KR Market which returned 12.9% over the past year.

Price Volatility

Is A044960's price volatile compared to industry and market?
A044960 volatility
A044960 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.9%
10% most volatile stocks in KR Market11.3%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A044960 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: A044960's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1970n/aSeung-Jo Kanghttps://www.eaglevet.com

Eagle Veterinary Technology Co.,Ltd manufactures and sells animal health care products in South Korea. The company offers antibiotics, antibacterials, anthelmintics, antihistamins, and in the form of injectable, feed additives, oral liquids, and soluble powders for swine, poultry, and bovine. Eagle Veterinary Technology Co.,Ltd also exports its products to New Zealand, Australia, Vietnam, Kenya, Uganda, Rwanda, and internationally.

Eagle Veterinary TechnologyLtd Fundamentals Summary

How do Eagle Veterinary TechnologyLtd's earnings and revenue compare to its market cap?
A044960 fundamental statistics
Market Cap₩104.04b
Earnings (TTM)₩4.39b
Revenue (TTM)₩40.47b

23.7x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A044960 income statement (TTM)
Revenue₩40.47b
Cost of Revenue₩26.91b
Gross Profit₩13.57b
Expenses₩9.18b
Earnings₩4.39b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)347.22
Gross Margin33.52%
Net Profit Margin10.85%
Debt/Equity Ratio13.1%

How did A044960 perform over the long term?

See historical performance and comparison

Valuation

Is Eagle Veterinary TechnologyLtd undervalued compared to its fair value and its price relative to the market?

5.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: A044960 (₩8230) is trading below our estimate of fair value (₩8748.99)

Significantly Below Fair Value: A044960 is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: A044960's PE Ratio (23.7x) is in line with the KR Pharmaceuticals industry average.

PE vs Market: A044960 is poor value based on its PE Ratio (23.7x) compared to the KR market (16x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A044960's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A044960 is overvalued based on its PB Ratio (2.6x) compared to the KR Pharmaceuticals industry average (1.8x).


Future Growth

How is Eagle Veterinary TechnologyLtd forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

34.8%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eagle Veterinary TechnologyLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Eagle Veterinary TechnologyLtd performed over the past 5 years?

10.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: A044960 has high quality earnings.

Growing Profit Margin: A044960's current net profit margins (10.8%) are higher than last year (4.3%).


Past Earnings Growth Analysis

Earnings Trend: A044960's earnings have grown by 10% per year over the past 5 years.

Accelerating Growth: A044960's earnings growth over the past year (171.2%) exceeds its 5-year average (10% per year).

Earnings vs Industry: A044960 earnings growth over the past year (171.2%) exceeded the Pharmaceuticals industry -14.8%.


Return on Equity

High ROE: A044960's Return on Equity (10.9%) is considered low.


Financial Health

How is Eagle Veterinary TechnologyLtd's financial position?


Financial Position Analysis

Short Term Liabilities: A044960's short term assets (₩25.6B) exceed its short term liabilities (₩8.0B).

Long Term Liabilities: A044960's short term assets (₩25.6B) exceed its long term liabilities (₩2.4B).


Debt to Equity History and Analysis

Debt Level: A044960 has more cash than its total debt.

Reducing Debt: A044960's debt to equity ratio has reduced from 37.7% to 13.1% over the past 5 years.

Debt Coverage: A044960's debt is well covered by operating cash flow (113%).

Interest Coverage: A044960's interest payments on its debt are well covered by EBIT (47.7x coverage).


Balance Sheet


Dividend

What is Eagle Veterinary TechnologyLtd current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate A044960's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A044960's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A044960's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A044960's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of A044960's dividend in 3 years as they are not forecast to pay a notable one for the KR market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Seung-Jo Kang (84 yo)

no data

Tenure

Seung-Jo Kang serves as Chief Executive Officer of Eagle Veterinary Technology Co. Ltd. and is responsible for General Management. Seung-Jo Kang also worked at Green Cross Corporation.Seung-Jo Kang gradua...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Eagle Veterinary Technology Co.,Ltd's employee growth, exchange listings and data sources


Key Information

  • Name: Eagle Veterinary Technology Co.,Ltd
  • Ticker: A044960
  • Exchange: KOSDAQ
  • Founded: 1970
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₩104.043b
  • Shares outstanding: 12.64m
  • Website: https://www.eaglevet.com

Location

  • Eagle Veterinary Technology Co.,Ltd
  • #235-34, Chusa-ro
  • Sinam-Myeon
  • Yesan
  • Chungcheongnam-do
  • 32417
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/25 16:09
End of Day Share Price2021/11/25 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.